SCHEMBL12293240

SCHEMBL12293240

CC(C)(C)c1c[nH]c2ccc(OCc3ccccc3)cc12

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 4/20 0.60
KDM4E B2RXH2 1/20 0.60
MAPT P10636 1/20 0.60
HTR1D P28221 5/20 0.59
LTA4H P09960 4/20 0.58
PLA2G2A P14555 4/20 0.58
SLC6A4 P31645 1/20 0.57
MEN1 O00255 2/20 0.53
KMT2A Q03164 2/20 0.53
POLB P06746 1/20 0.53
HSP90AA1 P07900 1/20 0.53
HSP90AB1 P08238 1/20 0.53
IMPDH2 P12268 1/20 0.51
HTR1A P08908 2/20 0.50
HTR1B P28222 2/20 0.50
ESR1 P03372 1/20 0.49
GAA P10253 1/20 0.49
GPR55 Q9Y2T6 1/20 0.49
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5648583 0.90 TRPM8 (0.60) TRPM8KDM4EMAPTHTR1DLTA4H
SCHEMBL27725148 0.82 TRPM8 (0.53) TRPM8KDM4EMAPTHTR1DLTA4H
SCHEMBL2004881 0.82 TRPM8 (0.64) TRPM8KDM4EMAPTHTR1DLTA4H
SCHEMBL5808051 0.81 TRPM8 (0.59) TRPM8KDM4EMAPTHTR1DLTA4H
SCHEMBL14174678 0.80 TRPM8 (0.72) TRPM8KDM4EMAPTHTR1DLTA4H
SCHEMBL9772869 0.80 TRPM8 (0.68) TRPM8KDM4EMAPTHTR1DLTA4H
SCHEMBL12614535 0.80 TRPM8 (0.61) TRPM8KDM4EMAPTHTR1DLTA4H
SCHEMBL2007192 0.80 TRPM8 (0.72) TRPM8KDM4EMAPTHTR1DLTA4H
SCHEMBL27664101 0.79 IMPDH2 (0.58) TRPM8KDM4EMAPTHTR1DLTA4H
SCHEMBL29007183 0.79 TRPM8 (0.76) TRPM8KDM4EMAPTHTR1DLTA4H

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110224231-A1 Novel Lactams as Beta Secretase Inhibitors PFIZER INC. (US) 2011-09-15 US disclosed
US-7244847-B2 Benzimidazole compounds ISIS PHARMACEUTICALS, INC. (US) 2007-07-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110224231-A1 Novel Lactams as Beta Secretase Inhibitors BACE1, BACE2, APH1B TRPM8 4459/4885KDM4E 3232/4885MAPT 642/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.